KALA earnings date and last-quarter result: last quarter beat, P/E -0.25. Updated 2026-07-23.
KALA BIO (KALA) Research Hub
KALA BIO (KALA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.1862 USD (-2.05%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.25, market cap 0.02B. This hub links to the full technical, earnings and options research available for KALA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.1862 USD (-2.05%) |
| 52-week range | 0.172 USD – 3.71 USD |
| Trend regime | Range |
| 14-day RSI | 6.2 (Oversold) |
| Trailing P/E | -0.25 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
Available research for KALA
Covered Call on KALA: how it works, illustrative setup around the real 0.1862 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on KALA: how it works, illustrative setup around the real 0.1862 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on KALA: how it works, illustrative setup around the real 0.1862 USD price, max profit/loss, breakeven and when to use it. Educational.
KALA technical analysis: range, last 0.1862 USD, RSI 6.2, 52w range 0.172 USD–3.71 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is KALA in?
KALA BIO (KALA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is KALA in an uptrend or downtrend?
As of 2026-10-26, KALA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is KALA's trailing P/E ratio?
KALA's trailing P/E is -0.25, with a market cap of 0.02B. See the earnings research page for full valuation detail.